Supplement Editor:
Laurence Kennedy, MD
Contents
Incretin-based therapies for type 2 diabetes mellitus: New therapeutic mechanisms
Laurence Kennedy, MD
Current antihyperglycemic treatment strategies for patients with type 2 diabetes mellitus
Lawrence Blonde, MD
Role of the incretin pathway in the pathogenesis of type 2 diabetes mellitus
Jeffrey S. Freeman, DO
Patient and treatment perspectives: Revisiting the link between type 2 diabetes, weight gain, and cardiovascular risk
Anne L. Peters, MD, CDE
Advances in therapy for type 2 diabetes: GLP-1 receptor agonists and DPP-4 inhibitors
Jaime A. Davidson, MD
Redefining treatment success in type 2 diabetes mellitus: Comprehensive targeting of core defects
William T. Cefalu, MD; Robert J. Richards, MD; and Lydia Y. Melendez-Ramirez, MD
